Published in Pharma Investments, Ventures and Law Weekly, January 23rd, 2005
According to published research from Germany, "Endocardial electromechanical mapping (EEM) has been proposed as a method for myocardial viability assessment. However, the impact of EEM data on clinical outcome has not been studied before. We sought to assess the prognostic value of EEM in patients with left ventricular (LV) dysfunction undergoing percutaneous coronary intervention (PCI)."
"Seventy-five patients with coronary artery disease and IV dysfunction (angiographic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly